Alkynylnicotinamide-Based Compounds as ABL1 Inhibitors with Potent Activities against Drug-Resistant CML Harboring ABL1(T315I) Mutant Kinase
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):